Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1989 Jun;52(Suppl):13–17. doi: 10.1136/jnnp.52.suppl.13

Current theories on the cause of Parkinson's disease.

J W Langston 1
PMCID: PMC1033304  PMID: 2666574

Full text

PDF
13

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benedetti M. S., Keane P. E. Differential changes in monoamine oxidase A and B activity in the aging rat brain. J Neurochem. 1980 Nov;35(5):1026–1032. doi: 10.1111/j.1471-4159.1980.tb07856.x. [DOI] [PubMed] [Google Scholar]
  2. Calne D. B., Langston J. W. Aetiology of Parkinson's disease. Lancet. 1983 Dec 24;2(8365-66):1457–1459. doi: 10.1016/s0140-6736(83)90802-4. [DOI] [PubMed] [Google Scholar]
  3. Carlsson A., Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. J Neural Transm. 1976;38(3-4):271–276. doi: 10.1007/BF01249444. [DOI] [PubMed] [Google Scholar]
  4. Côté L. J., Kremzner L. T. Biochemical changes in normal aging in human brain. Adv Neurol. 1983;38:19–30. [PubMed] [Google Scholar]
  5. Duncan M. W., Kopin I. J., Garruto R. M., Lavine L., Markey S. P. 2-Amino-3 (methylamino)-propionic acid in cycad-derived foods is an unlikely cause of amyotrophic lateral sclerosis/parkinsonism. Lancet. 1988 Sep 10;2(8611):631–632. doi: 10.1016/s0140-6736(88)90671-x. [DOI] [PubMed] [Google Scholar]
  6. Graham D. G. On the origin and significance of neuromelanin. Arch Pathol Lab Med. 1979 Jul;103(7):359–362. [PubMed] [Google Scholar]
  7. Graham D. G., Tiffany S. M., Bell W. R., Jr, Gutknecht W. F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol. 1978 Jul;14(4):644–653. [PubMed] [Google Scholar]
  8. Graham D. G., Tiffany S. M., Vogel F. S. The toxicity of melanin precursors. J Invest Dermatol. 1978 Feb;70(2):113–116. doi: 10.1111/1523-1747.ep12541249. [DOI] [PubMed] [Google Scholar]
  9. Gupta M., Gupta B. K., Thomas R., Bruemmer V., Sladek J. R., Jr, Felten D. L. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults. Neurosci Lett. 1986 Oct 20;70(3):326–331. doi: 10.1016/0304-3940(86)90573-2. [DOI] [PubMed] [Google Scholar]
  10. Hirsch E., Graybiel A. M., Agid Y. A. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 1988 Jul 28;334(6180):345–348. doi: 10.1038/334345a0. [DOI] [PubMed] [Google Scholar]
  11. Lewin R. Environmental hypothesis for brain diseases strengthened by new data. Science. 1987 Jul 31;237(4814):483–484. doi: 10.1126/science.3603034. [DOI] [PubMed] [Google Scholar]
  12. McGeer P. L., Itagaki S., Akiyama H., McGeer E. G. Rate of cell death in parkinsonism indicates active neuropathological process. Ann Neurol. 1988 Oct;24(4):574–576. doi: 10.1002/ana.410240415. [DOI] [PubMed] [Google Scholar]
  13. Mochly-Rosen D., Chang F. H., Cheever L., Kim M., Diamond I., Gordon A. S. Chronic ethanol causes heterologous desensitization of receptors by reducing alpha s messenger RNA. Nature. 1988 Jun 30;333(6176):848–850. doi: 10.1038/333848a0. [DOI] [PubMed] [Google Scholar]
  14. Reinhard J. F., Jr, Diliberto E. J., Jr, Viveros O. H., Daniels A. J. Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8160–8164. doi: 10.1073/pnas.84.22.8160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Robinson D. S., Nies A., Davis J. N., Bunney W. E., Davis J. M., Colburn R. W., Bourne H. R., Shaw D. M., Coppen A. J. Ageing, monoamines, and monoamine-oxidase levels. Lancet. 1972 Feb 5;1(7745):290–291. doi: 10.1016/s0140-6736(72)90293-0. [DOI] [PubMed] [Google Scholar]
  16. Spencer P. S., Nunn P. B., Hugon J., Ludolph A. C., Ross S. M., Roy D. N., Robertson R. C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science. 1987 Jul 31;237(4814):517–522. doi: 10.1126/science.3603037. [DOI] [PubMed] [Google Scholar]
  17. Tabakoff B., Hoffman P. L., Lee J. M., Saito T., Willard B., De Leon-Jones F. Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med. 1988 Jan 21;318(3):134–139. doi: 10.1056/NEJM198801213180302. [DOI] [PubMed] [Google Scholar]
  18. Ward C. D., Duvoisin R. C., Ince S. E., Nutt J. D., Eldridge R., Calne D. B. Parkinson's disease in 65 pairs of twins and in a set of quadruplets. Neurology. 1983 Jul;33(7):815–824. doi: 10.1212/wnl.33.7.815. [DOI] [PubMed] [Google Scholar]
  19. Zetterström T., Herrera-Marschitz M., Ungerstedt U. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 1986 Jun 18;376(1):1–7. doi: 10.1016/0006-8993(86)90893-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES